← Leaderboards
Daniel Arkfeld
University Of Southern California
$347,081
Attributed
$347,081
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$347,081 · 1
By mechanism
M01$347,081 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Nunzio Bottini$23,475,201
- David Ko$2,344,909
- Rajindar S Sohal$8,787,511
- Andrea A. Kovacs$11,647,115
- Matthew Robert Pratt$5,834,380
Others in their field
Top investigators on “Carbohydrates”
- Robert Sackstein · Brigham And Women'S Hospital$23,640,386
- Frank M Sacks · Brigham And Women'S Hospital$23,399,903
- James Michael Pierce · University Of Georgia (Uga)$19,433,081
- James H Prestegard · University Of Georgia (Uga)$19,206,129
- Geert-Jan Boons · University Of Georgia (Uga)$16,957,104
- Dennis L. Kasper · Harvard Medical School$15,637,040
Research focus
CarbohydratesClinical ResearchClinical TrialsDrug Screening /EvaluationDrug WithdrawalHuman SubjectHuman Therapy EvaluationNonsteroidal Antiinflammatory AgentPlacebosRheumatoid ArthritisSkeletal Disorder ChemotherapySuperoxidesSynthetic Protein
Grant awards (5)
THERAFECTIN COMPARED TO PLACEBO IN RHEUMATOID ARTHRITIS WITHDRAWN FROM NSAID$0
M01 · FY2002 · RR
THERAFECTIN COMPARED TO PLACEBO IN RHEUMATOID ARTHRITIS WITHDRAWN FROM NSAID$155,764
M01 · FY2001 · RR
THERAFECTIN COMPARED TO PLACEBO IN RHEUMATOID ARTHRITIS WITHDRAWN FROM NSAID$0
M01 · FY2001 · RR
THERAFECTIN COMPARED TO PLACEBO IN RHEUMATOID ARTHRITIS WITHDRAWN FROM NSAID$155,764
M01 · FY2000 · RR
THERAFECTIN COMPARED TO PLACEBO IN RHEUMATOID ARTHRITIS WITHDRAWN FROM NSAID$35,553
M01 · FY2000 · RR